Literature DB >> 12006587

Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels.

Katherine J Nielsen1, Michael Watson, David J Adams, Anna K Hammarström, Peter W Gage, Justine M Hill, David J Craik, Linda Thomas, Denise Adams, Paul F Alewood, Richard J Lewis.   

Abstract

Mu-conotoxins are peptide inhibitors of voltage-sensitive sodium channels (VSSCs). Synthetic forms of mu-conotoxins PIIIA and PIIIA-(2-22) were found to inhibit tetrodotoxin (TTX)-sensitive VSSC current but had little effect on TTX-resistant VSSC current in sensory ganglion neurons. In rat brain neurons, these peptides preferentially inhibited the persistent over the transient VSSC current. Radioligand binding assays revealed that PIIIA, PIIIA-(2-22), and mu-conotoxins GIIIB discriminated among TTX-sensitive VSSCs in rat brain, that these and GIIIC discriminated among the corresponding VSSCs in human brain, and GIIIA had low affinity for neuronal VSSCs. (1)H NMR studies found that PIIIA adopts two conformations in solution due to cis/trans isomerization at hydroxyproline 8. The major trans conformation results in a three-dimensional structure that is significantly different from the previously identified conformation of mu-conotoxins GIIIA and GIIIB that selectively target TTX-sensitive muscle VSSCs. Comparison of the structures and activity of PIIIA to muscle-selective mu-conotoxins provides an insight into the structural requirements for inhibition of different TTX-sensitive sodium channels by mu-conotoxins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006587     DOI: 10.1074/jbc.M201611200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Binding modes of μ-conotoxin to the bacterial sodium channel (NaVAb).

Authors:  Rong Chen; Shin-Ho Chung
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

Review 2.  Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.

Authors:  Brad R Green; Grzegorz Bulaj; Raymond S Norton
Journal:  Future Med Chem       Date:  2014-10       Impact factor: 3.808

3.  A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.

Authors:  Sulan Luo; Dongting Zhangsun; Christina I Schroeder; Xiaopeng Zhu; Yuanyan Hu; Yong Wu; Maegan M Weltzin; Spencer Eberhard; Quentin Kaas; David J Craik; J Michael McIntosh; Paul Whiteaker
Journal:  FASEB J       Date:  2014-01-07       Impact factor: 5.191

4.  Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.

Authors:  Jennifer R Deuis; Yu Ling Lim; Silmara Rodrigues de Sousa; Richard J Lewis; Paul F Alewood; Peter J Cabot; Irina Vetter
Journal:  Neuro Oncol       Date:  2014-04-08       Impact factor: 12.300

5.  Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins.

Authors:  Ping Chen; Andreas Dendorfer; Rocio K Finol-Urdaneta; Heinrich Terlau; Baldomero M Olivera
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

Review 6.  The M-superfamily of conotoxins: a review.

Authors:  Reed B Jacob; Owen M McDougal
Journal:  Cell Mol Life Sci       Date:  2009-08-25       Impact factor: 9.261

7.  Structure, dynamics, and selectivity of the sodium channel blocker mu-conotoxin SIIIA.

Authors:  Shenggen Yao; Min-Min Zhang; Doju Yoshikami; Layla Azam; Baldomero M Olivera; Grzegorz Bulaj; Raymond S Norton
Journal:  Biochemistry       Date:  2008-09-18       Impact factor: 3.162

8.  Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeutics.

Authors:  Tiffany S Han; Min-Min Zhang; Aleksandra Walewska; Pawel Gruszczynski; Charles R Robertson; Thomas E Cheatham; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2009-03       Impact factor: 3.466

9.  Mammalian neuronal sodium channel blocker μ-conotoxin BuIIIB has a structured N-terminus that influences potency.

Authors:  Zhihe Kuang; Min-Min Zhang; Kallol Gupta; Joanna Gajewiak; Jozsef Gulyas; Padmanabhan Balaram; Jean E Rivier; Baldomero M Olivera; Doju Yoshikami; Grzegorz Bulaj; Raymond S Norton
Journal:  ACS Chem Biol       Date:  2013-04-16       Impact factor: 5.100

10.  NMR-based mapping of disulfide bridges in cysteine-rich peptides: application to the mu-conotoxin SxIIIA.

Authors:  Aleksandra Walewska; Jack J Skalicky; Darrell R Davis; Min-Min Zhang; Estuardo Lopez-Vera; Maren Watkins; Tiffany S Han; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj
Journal:  J Am Chem Soc       Date:  2008-10-03       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.